Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-25-025281
Filing Date
2025-05-13
Accepted
2025-05-13 21:47:28
Documents
1
Period of Report
2025-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1747187242.html 3  
1 FORM 3 wk-form3_1747187242.xml 3 1602
  Complete submission text file 0001628280-25-025281.txt   3060
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Parsey Merdad (Reporting) CIK: 0001792150 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36485 | Film No.: 25942387